AAAAAA

   
Results: 1-11 |
Results: 11
THE EFFECTS OF POLYDRUG USE WITH AND WITHOUT COCAINE ON MOTHER-INFANTINTERACTION AT 3 AND 6 MONTHS
Authors: MAYES LC FELDMAN R GRANGER RH HAYNES OM BORNSTEIN MH SCHOTTENFELD R
Citation: Lc. Mayes et al., THE EFFECTS OF POLYDRUG USE WITH AND WITHOUT COCAINE ON MOTHER-INFANTINTERACTION AT 3 AND 6 MONTHS, Infant behavior & development, 20(4), 1997, pp. 489-502
NONPHARMACOLOGIC APPROACHES TO SUBSTANCE-ABUSE TREATMENT
Authors: CARROLL KM SCHOTTENFELD R
Citation: Km. Carroll et R. Schottenfeld, NONPHARMACOLOGIC APPROACHES TO SUBSTANCE-ABUSE TREATMENT, The Medical clinics of North America, 81(4), 1997, pp. 927
6-MONTH FOLLOW-UP OF NALTREXONE AND PSYCHOTHERAPY FOR ALCOHOL DEPENDENCE
Authors: OMALLEY SS JAFFE AJ CHANG G RODE S SCHOTTENFELD R MEYER RE ROUNSAVILLE B
Citation: Ss. Omalley et al., 6-MONTH FOLLOW-UP OF NALTREXONE AND PSYCHOTHERAPY FOR ALCOHOL DEPENDENCE, Archives of general psychiatry, 53(3), 1996, pp. 217-224
COCAINE-ABUSING PARTURIENTS UNDERGOING CESAREAN-SECTION - A COHORT STUDY
Authors: KAIN ZN MAYES LC FERRIS CA PAKES J SCHOTTENFELD R
Citation: Zn. Kain et al., COCAINE-ABUSING PARTURIENTS UNDERGOING CESAREAN-SECTION - A COHORT STUDY, Anesthesiology, 85(5), 1996, pp. 1028-1035
DESIPRAMINE, AMANTADINE, OR FLUOXETINE IN BUPRENORPHINE-MAINTAINED COCAINE USERS
Authors: OLIVETO A KOSTEN TR SCHOTTENFELD R FALCIONI J ZIEDONIS D
Citation: A. Oliveto et al., DESIPRAMINE, AMANTADINE, OR FLUOXETINE IN BUPRENORPHINE-MAINTAINED COCAINE USERS, Journal of substance abuse treatment, 12(6), 1995, pp. 423-428
CHRONIC COCAINE ABUSE IN THE PARTURIENT - ANESTHETIC OUTCOMES
Authors: KAIN ZN FERRIS C MAYES L OCONNOR T SCHOTTENFELD R
Citation: Zn. Kain et al., CHRONIC COCAINE ABUSE IN THE PARTURIENT - ANESTHETIC OUTCOMES, Anesthesiology, 83(3A), 1995, pp. 967-967
THROMBOCYTOPENIA IN PREGNANT-WOMEN WHO USE COCAINE
Authors: KAIN ZN MAYES LC PAKES J ROSENBAUM SH SCHOTTENFELD R
Citation: Zn. Kain et al., THROMBOCYTOPENIA IN PREGNANT-WOMEN WHO USE COCAINE, American journal of obstetrics and gynecology, 173(3), 1995, pp. 885-890
COCAINE USE IN BUPRENORPHINE-MAINTAINED VS METHADONE-MAINTAINED PATIENTS
Authors: OLIVETO AH KOSTEN TR SCHOTTENFELD R ZIEDONIS D FALCIONI J
Citation: Ah. Oliveto et al., COCAINE USE IN BUPRENORPHINE-MAINTAINED VS METHADONE-MAINTAINED PATIENTS, The American journal on addictions, 3(1), 1994, pp. 43-48
COMPARING BUPRENORPHINE AND METHADONE-MAINTENANCE - REPLY
Authors: KOSTEN TR SCHOTTENFELD R ZIEDONIS D FALCIONI J
Citation: Tr. Kosten et al., COMPARING BUPRENORPHINE AND METHADONE-MAINTENANCE - REPLY, The Journal of nervous and mental disease, 182(4), 1994, pp. 246-246
BUPRENORPHINE VERSUS METHADONE-MAINTENANCE FOR OPIOID DEPENDENCE
Authors: KOSTEN TR SCHOTTENFELD R ZIEDONIS D FALCIONI J
Citation: Tr. Kosten et al., BUPRENORPHINE VERSUS METHADONE-MAINTENANCE FOR OPIOID DEPENDENCE, The Journal of nervous and mental disease, 181(6), 1993, pp. 358-364
COCAINE ABUSE AMONG METHADONE-MAINTAINED PATIENTS
Authors: OLIVETO A KOSTEN T SCHOTTENFELD R ZIEDONIS D
Citation: A. Oliveto et al., COCAINE ABUSE AMONG METHADONE-MAINTAINED PATIENTS, The American journal of psychiatry, 150(11), 1993, pp. 1755-1755
Risultati: 1-11 |